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Welcome to the international journey to improving human health
It is with great excitement that I welcome you to the International Journal of
Nanomedicine (IJN). This new journal has been launched to bring you the latest,
exciting, up-to-date research conducted at the intersection of nanotechnology and
medicine. As you will see in this issue alone, researchers from around the world are
actively pursuing numerous efforts to improve human health through nanotechnology;
it is truly an international effort! A recent survey found that governmental
nanotechnology programs were funding research worldwide up to an estimated US$5
billion (€3 billion) in 2004 alone (Wagner V and Zweck A 2005 September 30, pers
comm). Three countries in particular, the US, Germany, and Japan, have recently
given clear commitments to nanomedicine by establishing focused nanomedicine
research funding programs. These trends will only increase as the global interest in
nanomedicine is only in its infancy. In fact, the projected nanotechnology business
market to enhance medical products is expected to be about US$25 billion (or €15
billion) in 2012 (Wagner V and Zweck A 2005 September 30, pers comm).
Not only is nanomedicine a growing area of interest for business, but it is also a
growing area of interest for researchers. Nanomedicine research has surged over the
past decade, in particular, publication numbers have jumped from about 10 per year
in the late 1980s to more than 1200 in 2004 (Wagner V and Zweck A 2005 September
30, pers comm). Again, the equal global commitment to nanotechnology is shown
by the fact that 39%, 28%, and 22% of these publications originated from research
conducted in the US, Europe, and Asia, respectively (Wagner V and Zweck A 2005
September 30, pers comm). Nanomedicine now accounts for about 5% of
nanotechnology publications worldwide. To date, the dominant research field in
nanomedicine has been drug delivery, contributing 72% of the scientific papers,
followed by in vitro diagnostics contributing about 15% (the remainder come from
implants, tissue engineering, and other medical applications) (Wagner V and Zweck
A 2005 September 30, pers comm). Clearly, ample global research is being conducted
at the intersection of nanotechnology and medicine to warrant a journal specifically
dedicated to nanomedicine; this is the void that IJN will fill.
When introducing this journal to colleagues, however, one question that I was
often asked was: “What is nanomedicine?” While I believe this definition will continue
to evolve over the coming years, IJN uses the definition that nanomedicine is the
incorporation of nanotechnology into medicine. This did not satisfy many of my
colleagues as they quickly rebutted: “Well then, what is nanotechnology?” Again,
while I believe the definition of nanotechnology will continue to evolve over the
coming years, nanotechnology is generally defined as the use of materials whose
components exhibit significantly changed properties by gaining control of structures
at the atomic, molecular, and supramolecular levels.
Of particular importance in this definition is not only the fabrication of
nanomaterials (such as self-assembled chemical structures, particles, fibers, and
grains), but also the importance of doing so. That is, we as scientists must continue
to emphasize the usefulness of and reason to fabricate nanomaterials in the first
place. Only through such concerted efforts will others understand the novelty of
nano. IJN is committed to highlighting these novelties as they pertain to medicine.International Journal of Nanomedicine 2006:1(1) 2
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Our inaugural issue shows a number of examples of how
nanotechnology is being used to advance medicine: the
design of novel drug delivery systems to treat diseases, the
development of imaging tools that could assist a clinician
in diagnosis, the synthesis of better implants to bond to bone
and vascular, and the fabrication of tools that help
researchers better understand molecular events. All of these
examples show how a fundamental event at the nanoscale
is being exploited.
While it is true that researchers have long sought to
understand nanoscale events, the new era of merging
nanotechnology and medicine will advance human health.
For example, it has been suggested that as early as 370 BC,
the Greek philosopher Democratis proposed the theory of
atomic matter (Kumar 2005); this could certainly be our
first indication of the desire to understand nanoscale events.
Since then many scientists have followed this train of
thought, and in 1959 Richard Feynman predicted the
possibility of maneuvering matter atom by atom. Today, we
see the impact of nanotechnology in many traditional
disciplines, such as the computer industry. However, little
comprehensive attention has been paid to nanotechnology
applications in medicine; this is the specific focus of IJN –
to emphasize the ever-changing advancements in nano-
technology that are being used to prevent, diagnose, and
treat diseases.
With this brief introduction, I hope you will join me in
reading every issue of IJN to continuously learn and discover
the numerous daily advancements being made in
nanomedicine. I welcome you to this important, timely, new
journal and hope you will enjoy this exciting journey of
how nanomedicine is improving, and will continue to
improve human health!
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